These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3439403)

  • 1. Increased plasma apolipoprotein B levels and blood hyperviscosity in non-insulin-dependent diabetic patients: role in the occurrence of arterial hypertension.
    Solerte SB; Fioravanti M; Patti AL; Fedele P; Schifino N; Melzi D'eril GV; Gorrini M; Ferrari E
    Acta Diabetol Lat; 1987; 24(4):341-9. PubMed ID: 3439403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hemorheological factors on the development of hypertension in diabetic children.
    Cam H; Püşüroğlu K; Aydin A; Ercan M
    J Trop Pediatr; 2003 Jun; 49(3):164-7. PubMed ID: 12848207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation.
    Rivellese A; Riccardi G; Romano G; Giacco R; Patti L; Marotta G; Annuzzi G; Mancini M
    Diabetologia; 1988 Dec; 31(12):884-8. PubMed ID: 3240843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipids and lipoproteins in type 2 diabetic patients with persistent microalbuminuria.
    Seghieri G; Alviggi L; Caselli P; De Giorgio LA; Breschi C; Gironi A; Niccolai M; Bartolomei GC
    Diabet Med; 1990 Nov; 7(9):810-4. PubMed ID: 2148134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.
    O'Neal DN; Lewicki J; Ansari MZ; Matthews PG; Best JD
    Atherosclerosis; 1998 Jan; 136(1):1-8. PubMed ID: 9544725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of the risk factors of atherosclerosis in type-II diabetics with hypertension.
    Tkác I; Takác M
    Czech Med; 1990; 13(1):9-17. PubMed ID: 2350993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.
    Kazumi T; Hozumi T; Ishida Y; Ikeda Y; Kishi K; Hayakawa M; Yoshino G
    Diabetes Care; 1999 Jul; 22(7):1176-80. PubMed ID: 10388985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.
    Wägner AM; Pérez A; Calvo F; Bonet R; Castellví A; Ordóñez J
    Diabetes Care; 1999 May; 22(5):812-7. PubMed ID: 10332687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of lipid metabolism and rheologic properties after successful pancreas and kidney transplantation.
    Abendroth D; Landgraf R; Pfeiffer M; Reininger J; Seidel D; Land W
    Transpl Int; 1994; 7 Suppl 1():S417-9. PubMed ID: 11271269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension.
    Hunt SC; Wu LL; Hopkins PN; Stults BM; Kuida H; Ramirez ME; Lalouel JM; Williams RR
    Arteriosclerosis; 1989; 9(3):335-44. PubMed ID: 2497719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of angiographically defined coronary artery disease and plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose tolerance.
    Fujiwara R; Kutsumi Y; Hayashi T; Nishio H; Koshino Y; Shimada Y; Nakai T; Miyabo S
    Am J Cardiol; 1995 Jan; 75(2):122-6. PubMed ID: 7810485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential role of apolipoprotein B in the risk stratification of diabetic patients with dyslipidaemia.
    Al-Bahrani AI; Bakhiet CS; Bayoumi RA; Al-Yahyaee SA
    Diabetes Res Clin Pract; 2005 Jul; 69(1):44-51. PubMed ID: 15904989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary excretion of albumin and lipid abnormalities in hypertensive insulin-dependent diabetics].
    Suraniti S; Giraud P; Hallab M; Simard G; Girault A; Fressinaud P; Marre M
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1253-7. PubMed ID: 2124464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive lipid-lowering strategy in patients with diabetes mellitus.
    Kanters SD; Algra A; de Bruint TW; Erkelens DW; Banga JD
    Diabet Med; 1999 Jun; 16(6):500-8. PubMed ID: 10391399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus.
    Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG
    Metabolism; 1998 Mar; 47(3):250-6. PubMed ID: 9500558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Egg consumption as part of an energy-restricted high-protein diet improves blood lipid and blood glucose profiles in individuals with type 2 diabetes.
    Pearce KL; Clifton PM; Noakes M
    Br J Nutr; 2011 Feb; 105(4):584-92. PubMed ID: 21134328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertriglyceridemic hyperapoB in type 2 diabetes.
    Sniderman AD; Lamarche B; Tilley J; Seccombe D; Frohlich J
    Diabetes Care; 2002 Mar; 25(3):579-82. PubMed ID: 11874951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study.
    Brouwers MC; Troutt JS; van Greevenbroek MM; Ferreira I; Feskens EJ; van der Kallen CJ; Schaper NC; Schalkwijk CG; Konrad RJ; Stehouwer CD
    Atherosclerosis; 2011 Jul; 217(1):263-7. PubMed ID: 21497351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes.
    Dullaart RP; Riemens SC; Scheek LM; Van Tol A
    Eur J Clin Invest; 1999 Aug; 29(8):663-71. PubMed ID: 10457149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.